1-8 of 8
James ignatz-Hoover
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1B/2A study of weekly decitabine and venetoclax treatment as maintenance therapy in high-risk myeloid malignancy patients post allogeneic stem cell transplantation

Free
Sophia Balderman, James Ignatz-Hoover, Claudio Brunstein, Yogen Saunthararajah, Ben Tomlinson
Journal: Blood
Blood (2025) 146 (Supplement 1): 2510.
https://doi.org/10.1182/blood-2025-2510
Published: 2025
Journal Articles

No CARs for miles: Geographic disparities in access to multiple myeloma CAR-T therapy

Free
Michael Daunov, Olga Lytvynova, R. Benjamin Gorham, Weichuan Dong, Siran Koroukian, James Ignatz-Hoover
Journal: Blood
Blood (2025) 146 (Supplement 1): 2816.
https://doi.org/10.1182/blood-2025-2816
Published: 2025
Journal Articles

Synthetic lethal targeting of PSMC2-dependent p97-adapted proteasome complexes that confer chemoresistance in multiple myeloma

Free
James Driscoll, James Ignatz-Hoover, Ehsan Malek, John D'Cruz, Wei Huang, Derek Taylor
Journal: Blood
Blood (2025) 146 (Supplement 1): 2176.
https://doi.org/10.1182/blood-2025-2176
Published: 2025
Journal Articles

Cost-effectiveness of CAR-T cell therapy compared to bispecific T-cell engagers in Relapsed/Refractory multiple myeloma: A retrospective study using a markov model

Free
Harry Balanta Murcia, James Ignatz-Hoover, Nikki Agarwal
Journal: Blood
Blood (2025) 146 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2025-4423
Published: 2025
Journal Articles

Pharmacologic activators of immunoproteasomes unmask actionable public and private neoantigens in multiple myeloma patients

Free
James Driscoll, James Ignatz-Hoover, John D'Cruz, Dahlia Messeloff, Luke D'Cruz, Nida Mubin, Wei Huang, Derek Taylor
Journal: Blood
Blood (2025) 146 (Supplement 1): 3954.
https://doi.org/10.1182/blood-2025-3954
Published: 2025
Journal Articles

Proteasome Regulatory Atpases PSMC2 and PSMC6 Modulate Proteosome Inhibitor Sensitivity and Correlate with Survival in Multiple Myeloma

Free
James Ignatz-Hoover, E Ricky Chan, Ehsan Malek, James J. Driscoll
Journal: Blood
Blood (2022) 140 (Supplement 1): 4305–4306.
https://doi.org/10.1182/blood-2022-170510
Published: 2022
Journal Articles

Towards CD177 As a Predictive Biomarker for Hypomethylating Agent Response in Myelodysplastic Syndrome

Free
James Ignatz-Hoover, Pingfu Fu, Shufen Cao, Benjamin Tomlinson, Howard Meyerson
Journal: Blood
Blood (2021) 138 (Supplement 1): 4665.
https://doi.org/10.1182/blood-2021-153761
Published: 2021
Journal Articles

Changes in Subcellular Localization of GSK3β As a Novel Driver of AML

Free
James ignatz-Hoover, Isaac Ghansah, Masumi Ueda, MD, Victoria Wang, Hillard M Lazarus, MD, Marcos de Lima, MD, David Wald, PhD MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1226.
https://doi.org/10.1182/blood.V130.Suppl_1.1226.1226
Published: 2017